Stockreport

Amylyx Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025

Amylyx Pharmaceuticals, Inc.  (AMLX) 
PDF CAMBRIDGE, Mass.--(BUSINESS WIRE)--Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) will report its third quarter 2025 financial results on Th [Read more]